Patents by Inventor Mohammed Shameem

Mohammed Shameem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable pegylated interferon formulation
    Patent number: 7632491
    Abstract: The present invention relates to lyophilized formulations of pegylated interferon which are prepared using trehalose as a cryoprotectant. The formulations have a low moisture content, which helps stabilize the pegylated interferon during storage of the formulations at room temperature. In addition, methods for preparing these formulations are provided.
    Type: Grant
    Filed: August 11, 2005
    Date of Patent: December 15, 2009
    Assignee: Schering Corporation
    Inventors: Mohammed Shameem, Anita Dabbara
  • Abuse Resistant Opioid Transdermal Delivery Device Containing Opioid Antagonist Microspheres
    Publication number: 20080233178
    Abstract: The present invention provides abuse-resistant transdermal delivery devices containing an opioid agonist intended for analgesic purposes in pain patients.
    Type: Application
    Filed: February 15, 2005
    Publication date: September 25, 2008
    Applicant: EURO-CELTIQUE S.A.
    Inventors: Bruce Reidenberg, Ihor Shevchuk, Lino Tavares, Richard Maskiewicz, Kevin Long, Mohammed Shameem
  • Stable pegylated interferon formulation
    Publication number: 20060051320
    Abstract: The present invention relates to lyophilized formulations of pegylated interferon which are prepared using trehalose as a cryoprotectant. The formulations have a low moisture content, which helps stabilize the pegylated interferon during storage of the formulations at room temperature. In addition, methods for preparing these formulations are provided.
    Type: Application
    Filed: August 11, 2005
    Publication date: March 9, 2006
    Inventors: Mohammed Shameem, Anita Dabbara
  • Local anesthetic, and method of use
    Publication number: 20030152637
    Abstract: This invention relates to pharmaceutical formulations administered via parenteral methods, which provide a prolonged localized analgesic effect. More particularly, the present invention concerns a pharmaceutically acceptable biocompatible biodegradable carrier containing a local anesthetic and the parenteral administration of such carrier in a manner such that a localized analgesic effect is attained for a prolonged period of time.
    Type: Application
    Filed: January 25, 2002
    Publication date: August 14, 2003
    Inventors: Mark Chasin, Glenn Van Buskirk, Richard Maskiewicz, Amol Ketkar, Kevin Burton, Mohammed Shameem, Craig Landau, Celia Coles, Ruth Swanton, Peter Lacouture
  • Formulations and methods for providing prolonged local anesthesia
    Patent number: 6451335
    Abstract: A formulation for inducing sustained regional local anesthesia in a patient comprising a substrate comprising a local anesthetic and an effective amount of a biocompatible, biodegradable, controlled release material prolonging the release of the local anesthetic from the substrate to obtain a reversible local anesthesia when implanted or injected in a patient, and a non-toxic augmenting agent effective to prolong the duration of the local anesthesia for a time period longer than that obtainable from the substrate without the augmenting agent. In preferred embodiments, the controlled release material is a low molecular weight, acid-terminated polymer. A further aspect of the invention is directed to such formulations which release the local anesthetic in two phases, the first a rapid “bolus” to initiate anesthesia and a second, slower release to maintain anesthesia.
    Type: Grant
    Filed: July 2, 1998
    Date of Patent: September 17, 2002
    Assignee: Euro-Celtique S.A.
    Inventors: Paul Goldenheim, Donna Donigi-Gale, Kevin Burton, Mohammed Shameem, Amol Ketkar, Mark Chasin, Richard Maskiewicz